Corporate Banner
Satellite Banner
Technology Networks Header
Tuesday, September 02, 2014
Technology Networks
 
Register | Sign in
Home Page>Products
  Product News
Biotage Launches ACI™ - Accelerated Chromatographic Isolation
Monday, June 30, 2014
Biotage announces the launch of ACI™ (Accelerated Chromatographic Isolation), a new advance converting simple flash purification into a faster and more economical way to isolate pure compounds.

Promega Introduces New Mass Spec Reagents, IdeS Protease and Human and Yeast Protein Extracts
Thursday, June 26, 2014
New reagents enable optimal digestion, method development and instrument monitoring for LC/MS

Agilent Introduces First-Ever Electron Ionization GC/MS/MS System
Tuesday, June 17, 2014
The 7010 Triple Quadrupole GC/MS system with attogram-level sensitivity.

Agilent Introduces Single Quadrupole Mass Detector for Chromatographers
Tuesday, June 17, 2014
6120VL MS provides mass confirmation, increased sensitivity and selectivity.

Agilents' New 6495 LC/MS Triple Quadrupole System
Tuesday, June 17, 2014
Provides confident quantitation and confirmation for most demanding applications.

Agilent to Distribute Cerno's Calibration and Analysis Software with GC/MSD Systems
Tuesday, June 17, 2014
Novel program increases lab accuracy and unknown compound identification with single-quadrupole instrumentation.

Agilent Integrates Sophisticated Target Deconvolution Capabilities into MassHunter Software
Tuesday, June 17, 2014
Robust quantitative/qualitative data easily extracted from complex samples.

Agilent Solutions for SFC with Mass Spectrometric Detection
Tuesday, June 17, 2014
Company’s solutions for supercritical fluid chromatography streamline high-volume analysis of complex compounds.

Protea Announces HRAM Analytical Services
Tuesday, June 17, 2014
Adds HRAM to its mass spectrometry based molecular imaging and LC-MS bioanalytical services portfolio.

<< 1 2 3 4 5 6 7 >>
Showing Results 11 - 20 of 1093
Scientific News
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Shenogen and Chemizon Announce Drug Discovery Collaboration Focused on Oncology and Endocrine Disorders
The agreement will create small molecule therapeutics targeting modulators of the ER-alpha 36 receptor.
Dutch Public-Private Partnership Invests 28 Million Euro on Research into Personalized Medicine
The Netherlands' three Top Institutes for life-science research announce a joint research target to bring personalized medicine closer to reality.
FDA Grants Orphan Drug Status for Quark's QPI-1002 for the Prophylaxis of DGF in Kidney Transplant Patients
Company completes enrollment and dosing in the dose-escalation safety portion of a Phase 1/2 study.
Oncolytics Biotech® Receives MHRA Approval to Conduct Phase 3 Trial for REOLYSIN®
Conducting the trials in U.S. and Europe will allow Company to access the physicians that have worked with REOLYSIN in head and neck cancers.
Skyscraper Banner
Skyscraper Banner
Follow TechNetcom1 on Twitter
Technology Networks Ltd. on LinkedIn
Go to LabTube.tv